What Heron Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 19 | 55 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 198,066 | 1,098,471 |
| Disposed | 28,302 | 34,059 |
| Net activity | +169,764 | +1,064,412 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Duarte Ira | EVP, Chief Financial Officer | Oct 19 | Withheld — tax / exercise cost · F | −1,102 | $0.36 | −$397 | 284,671 |
| Duarte Ira | EVP, Chief Financial Officer | Oct 19 | Exercise / conversion · M | +3,874 | — | — | 285,773 |
| Forbes William P | EVP, Chief Development Officer | Oct 19 | Withheld — tax / exercise cost · F | −1,102 | $0.36 | −$397 | 243,945 |
| Forbes William P | EVP, Chief Development Officer | Oct 19 | Exercise / conversion · M | +3,874 | — | — | 245,047 |
| Collard Craig A | Chief Executive Officer | Oct 19 | Withheld — tax / exercise cost · F | −3,360 | $0.36 | −$1.21K | 866,929 |
| Collard Craig A | Chief Executive Officer | Oct 19 | Exercise / conversion · M | +13,797 | — | — | 870,289 |
| Hensley Mark Earl | Chief Operating Officer | Aug 06 | Withheld — tax / exercise cost · F | −8,888 | $0.50 | −$4.44K | 170,901 |
| Hensley Mark Earl | Chief Operating Officer | Aug 06 | Exercise / conversion · M | +31,250 | — | — | 179,789 |
| Forbes William P | EVP, Chief Development Officer | Jul 31 | Withheld — tax / exercise cost · F | −3,326 | $0.50 | −$1.66K | 241,173 |
| Forbes William P | EVP, Chief Development Officer | Jul 31 | Exercise / conversion · M | +11,694 | — | — | 244,499 |
| Duarte Ira | EVP, Chief Financial Officer | Jul 31 | Withheld — tax / exercise cost · F | −3,326 | $0.50 | −$1.66K | 281,899 |
| Duarte Ira | EVP, Chief Financial Officer | Jul 31 | Exercise / conversion · M | +11,694 | — | — | 285,225 |
| Hensley Mark Earl | Chief Operating Officer | Jul 31 | Exercise / conversion · M | +11,769 | — | — | 148,539 |
| Collard Craig A | Chief Executive Officer | Jul 31 | Exercise / conversion · M | +34,789 | — | — | 856,492 |
| Forbes William P | EVP, Chief Development Officer | Jul 30 | Withheld — tax / exercise cost · F | −3,348 | $0.50 | −$1.67K | 232,805 |
| Forbes William P | EVP, Chief Development Officer | Jul 30 | Exercise / conversion · M | +11,769 | — | — | 236,153 |
| Duarte Ira | EVP, Chief Financial Officer | Jul 30 | Withheld — tax / exercise cost · F | −3,850 | $0.50 | −$1.93K | 273,531 |
| Duarte Ira | EVP, Chief Financial Officer | Jul 30 | Exercise / conversion · M | +13,535 | — | — | 277,381 |
| Collard Craig A | Chief Executive Officer | Jul 30 | Exercise / conversion · M | +50,021 | — | — | 821,703 |
| Duarte Ira | EVP, Chief Financial Officer | Jul 19 | Withheld — tax / exercise cost · F | −1,101 | $0.47 | −$517 | 263,846 |
Loading...